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Supplementary Figure 1. Serial transplantations of NPC PDXs.
(a) Serial transplantation of NPC tissues was performed to maintain Xeno23 in subrenal growth in NOD/SCID mice. From T0 (before transfer) to T3 (the 3 rd transfer), the growth of Xeno23 was very slow. Robust growth was observed from T4 (the 4 th transfer) onwards.
(b) The growth of Xeno43 was observed at T0 after implanting NPC tumor tissues under renal capsule of NOD/SCID mice and keeping for growth for 122 days. However, the size of this PDX shrank in mice during T1 (the 1 st transfer) to T5 (the 5 th transfer), and eventually the growth stopped.
Supplementary Figure 4. Comparison of cell proliferation rates of NPC43 at different passages.
The proliferation rate of NPC43 cells was evaluated by thymidine incorporation assay. Results revealed the increased thymidine incorporation in NPC43 at higher population doublings. Data are shown as mean ± SD from 3 independent experiments. * p < 0.05 in a two-tailed t-test. The following information is illustrated in order from inner to outer rings based on WGS data analysis: Ring 1 (innermost) for structural variants (orange, inter-chromosomal rearrangement; blue, intra-chromosomal rearrangement); Ring 2 for copy number variants (green, copy number loss; red, copy number gain; range: -2 to +4); Ring 3 for non-synonymous single-nucleotide variants or small indels (purple, missense; black, splicing; orange, nonsense; red, frameshift; green, inframe indel; brown, others) with allele frequency indicated by the size of each dot (0%, 20%, 40%, 60%, 80%, 100% or more); Ring 4 for density of SNVs/small indels (0 per Mbps, 20, 40, 60, 80, 100, 120, 140, 160 or more); Ring 5 (outermost) for chromosome scale at 1 Mbps (shades of gray, cytobands; red, centromere).
Xeno32
Supplementary Figure 13 . Circos plot depicting the somatic alterations in Xeno32. The following information is illustrated in order from inner to outer rings based on WGS data analysis: Ring 1 (innermost) for structural variants (orange, inter-chromosomal rearrangement; blue, intra-chromosomal rearrangement); Ring 2 for copy number variants (green, copy number loss; red, copy number gain; range: -2 to +4); Ring 3 for non-synonymous single-nucleotide variants or small indels (purple, missense; black, splicing; orange, nonsense; red, frameshift; green, inframe indel; brown, others) with allele frequency indicated by the size of each dot (0%, 20%, 40%, 60%, 80%, 100% or more); Ring 4 for density of SNVs/small indels (0 per Mbps, 20, 40, 60, 80, 100, 120, 140, 160 or more); Ring 5 (outermost) for chromosome scale at 1 Mbps (shades of gray, cytobands; red, centromere).
NPC43

Supplementary Figure 14. Circos plot depicting the somatic alterations in NPC43.
The following information is illustrated in order from inner to outer rings based on WGS data analysis: Ring 1 (innermost) for structural variants (orange, inter-chromosomal rearrangement; blue, intra-chromosomal rearrangement); Ring 2 for copy number variants (green, copy number loss; red, copy number gain; range: -2 to +4); Ring 3 for non-synonymous single-nucleotide variants or small indels (purple, missense; black, splicing; orange, nonsense; red, frameshift; green, inframe indel; brown, others) with allele frequency indicated by the size of each dot (0%, 20%, 40%, 60%, 80%, 100% or more); Ring 4 for density of SNVs/small indels (0 per Mbps, 20, 40, 60, 80, 100, 120, 140, 160 or more); Ring 5 (outermost) for chromosome scale at 1 Mbps (shades of gray, cytobands; red, centromere).
Xeno47
Supplementary Figure 15 . Circos plot depicting the somatic alterations in Xeno47. The following information is illustrated in order from inner to outer rings based on WGS data analysis: Ring 1 (innermost) for structural variants (orange, inter-chromosomal rearrangement; blue, intra-chromosomal rearrangement); Ring 2 for copy number variants (green, copy number loss; red, copy number gain; range: -2 to +4); Ring 3 for non-synonymous single-nucleotide variants or small indels (purple, missense; black, splicing; orange, nonsense; red, frameshift; green, inframe indel; brown, others) with allele frequency indicated by the size of each dot (0%, 20%, 40%, 60%, 80%, 100% or more); Ring 4 for density of SNVs/small indels (0 per Mbps, 20, 40, 60, 80, 100, 120, 140, 160 or more); Ring 5 (outermost) for chromosome scale at 1 Mbps (shades of gray, cytobands; red, centromere).
Xeno76
Supplementary Figure 16 . Circos plot depicting the somatic alterations in Xeno76. The following information is illustrated in order from inner to outer rings based on WGS data analysis: Ring 1 (innermost) for structural variants (orange, inter-chromosomal rearrangement; blue, intra-chromosomal rearrangement); Ring 2 for copy number variants (green, copy number loss; red, copy number gain; range: -2 to +4); Ring 3 for non-synonymous single-nucleotide variants or small indels (purple, missense; black, splicing; orange, nonsense; red, frameshift; green, inframe indel; brown, others) with allele frequency indicated by the size of each dot (0%, 20%, 40%, 60%, 80%, 100% or more); Ring 4 for density of SNVs/small indels (0 per Mbps, 20, 40, 60, 80, 100, 120, 140, 160 or more); Ring 5 (outermost) for chromosome scale at 1 Mbps (shades of gray, cytobands; red, centromere). 
Type of mutation
Xeno23 NM_015247; 50772807 3k bp deletion CYLD nt#50772807 nt#50776131 Exon 2 Exon 3 Exon 19 Exon 20 A C G T CYLD a Xeno47 NM_015247; 50827080 60k bp deletion CYLD nt#50827080 nt#50887064 Exon 1 Exon 2 Exon
EBV-ve EBV+ve
Supplementary Figure 20. Differentially expressed genes in EBV-ve and EBV+ve NPC cell lines and xenografts.
Heatmap showing 1974 differentially expressed genes in EBV-ve (HK1, NPC38 and NPC53) and EBV+ve (NPC43, C17, C666-1, Xeno23, 32, 47 and 76) samples. Briefly, RNA sequencing was performed to characterize the transcriptome profiles of newly established NPC PDXs and cell lines, together with well-established NPC cell lines, including HK1 (EBV-ve, derived from well differentiated squamous carcinoma), C17 (EBV+ve, recently developed from C17 xenograft) and C666-1 (EBV+ve, derived from xenograft X666). Gene expression levels as normalized read counts quantified by RSEM were subjected to EBSeq comparison to determine the differentially expressed genes between EBV+ve and EBV-ve cohorts. The genes with FDR q-value below 0.05 were considered as significantly upregulated or downregulated. Heatmap was drawn and gene pattern clustering was analyzed using pheatmap R package. Red indicates high relative expression while blue indicates low relative expression. Range: -2 to 2. Figure 21 . Activation of NF-κB and other cancer-associated pathways in EBV+ve NPC cells and xenografts. RNA sequencing was performed and gene expression levels were quantified as stated in Materials and Methods. The expression levels of all protein-coding genes were subject to gene set enrichment analysis (GSEA) for pathway analysis. The expression of genes in two cohorts was compared, including EBV-ve (HK1, NPC38 and NPC53) and EBV+ve (C666-1, C17, NPC43, Xeno23, 32, 47 and 76). For a brief illustration for GSEA enrichment plot, enrichment score (ES) indicates the degree to which the specified gene set is overrepresented at the top or bottom of a ranked list of total protein-coding genes in all PDXs/cell lines. The normalized enrichment score (NES) computes the density of modified genes in the dataset with the random expectancies, normalized by the number of genes found in each gene cluster. The false discovery rate (FDR) is calculated by comparing the actual data with 1000 Monte-Carlo simulations. For each enrichment plot, the top portion reveals the running ES for the specified gene set; the middle portion indicates where the member of the gene set appears in the ranked list of genes; the bottom portion shows the value of the ranking metric as a measurement of a gene's correlation with a phenotype (EBV+ve or EBV-ve). A significant enrichment in GGGNNTTTCC_NFKB gene set (a) was indicated by GSEA results, which was a gene set previously identified by NF-κB regulatory motif analysis in promoter regions of human genome. EBV+ve samples exhibited enhanced activation of NF-κB pathway evidenced by the upregulated NF-κB targets, as compared to the EBV-ve cohort. GSEA results also revealed significant enrichment in HALLMARK Epithelial-Mesenchymal Transition gene set (b), HALLMARK Notch signaling gene set (c), and HALLMARK Wnt-beta-catenin signaling gene set (d) with gene upregulation in EBV+ve cohort as compared to the EBV-ve counterpart, with NES, pvalue and FDR q-value indicated.
Supplementary Figure 22. Significant upregulated expression of NF-κB targets in EBV+ve NPC cells and xenografts revealed by RNA sequencing analysis.
Heatmap illustrating the upregulated NF-κB targets in EBV+ve cohort (including NPC43, C666-1, C17, Xeno23, 32, 47 and 76) as compared to EBV-ve cohort (including HK1, NPC38 and NPC53). RNA sequencing was performed and gene expression levels were quantified as stated. Putative NF-κB targets identified by previous reports (illustrated in Materials and Methods) were selected for comparison by EBSeq between EBV+ve and EBV-ve cohorts. The genes with FDR q-value below 0.05 were considered as significantly upregulated NF-κB targets in EBV+ve cohort. Heatmap was drawn and gene pattern clustering was analyzed using pheatmap R package. Red indicates high relative expression while blue indicates low relative expression. Range: -2 to 2. The upregulated expression pattern of NF-κB targets is consistent with the genomic profiles of EBV+ve NPC models with commonly identified loss-of-function mutations in negative regulators of NF-κB pathway. Phylogeny trees depicting the phylogenetic similarity between the sequences of protein coding regions of LMP1 gene (a) and EBNA1 gene (b) in the newly assembled EBV genomes (Xeno23, 32, 47, 76 and NPC43) and other publicly available sequences of EBV. Briefly, the non-human and non-mouse reads from WGS were aligned to the reference EBV genome (NC_007605) using BWA software. The generated BAM files were subjected to SAMtools software for pile-up files and assessment of coverage of reads. After reads trimming and calculation of average coverage of reads, high-quality reads were assembled using Velvet with k-mer length optimized. The sequences of EBV genes in the new assembled EBV sequences were subjected to the multiple sequence alignment with MAFFT with other publicly available sequences. The aligned sequences were visualized and edited using Jalview software. Phylogenetic analysis was performed using MEGA7 by neighbour-joining algorithm, and phylogenetic tree was generated and drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite Likelihood method. The results indicate that the LMP1 and EBNA1 gene sequences in Xeno23, 32, 47, 76 and NPC43 show close phylogenetic similarity with those in NPC-EBV, including HKNPC1-9, M81, GD2 and C666-1, but are distinct from the gene sequences in other EBV genomes, including EBV from gastric cancer (YCCEL1 and SNU719) and EBV from B lymphoma (B95.8 and Mutu). 
